|
Market Closed -
Nasdaq
00:00:00 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
-.--% | +82.49% |
| Market Cap | 9.01B 8.07B 7.42B 6.73B 12.57B 856B 12.81B 88.52B 35.53B 450B 33.81B 33.1B 1,419B | P/E 2024 |
-13.8x | P/E 2025 | -9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 8.03B 7.19B 6.62B 5.99B 11.21B 763B 11.42B 78.9B 31.67B 401B 30.14B 29.5B 1,265B | EV / Sales 2024 |
3,310x | EV / Sales 2025 | 447x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRNX | Delayed | |
CBOE
| CRNX | Real-time |
Last Transcript: Crinetics Pharmaceuticals
| 1 day | +0.13% | ||
| 3 months | +1.28% | ||
| 6 months | +120.99% | ||
| Current year | +82.49% |
| Current year | 32.3 |  | 85.01 |
| 1 year | 32.3 | | 85.01 |
| 3 years | 24.1 | | 85.01 |
| 5 years | 15.23 | | 85.01 |
| 10 years | 10.63 | | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Wagner
PSD | President | 57 | 01/09/2026 |
Cory Jubinville
PRN | Corporate Officer/Principal | - | 01/02/2026 |
Omar White
SEC | Corporate Secretary | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Wagner
BRD | Director/Board Member | 57 | 01/09/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Issuer sale | Chief Financial Officer | -209,427 | 0.1986% | ||
| 01/09/26 | Issuer sale | Founder | -905,240 | 0.8585% | ||
| 01/09/26 | Issuer sale | Chairman | -232,151 | 0.2202% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.04M 931K 856K 776K 1.45M 98.65M 1.48M 10.21M 4.1M 51.89M 3.9M 3.82M 164M | 7.7M 6.89M 6.34M 5.74M 10.74M 731M 10.94M 75.61M 30.35M 384M 28.88M 28.27M 1.21B |
| Net income | -298M -267M -246M -223M -416M -28.33B -424M -2.93B -1.18B -14.9B -1.12B -1.1B -47B | -465M -417M -383M -347M -649M -44.18B -661M -4.57B -1.84B -23.24B -1.75B -1.71B -73.29B |
| Net Debt | -1.3B -1.17B -1.07B -972M -1.82B -124B -1.85B -12.79B -5.14B -65.05B -4.89B -4.78B -205B | -979M -877M -807M -731M -1.37B -92.99B -1.39B -9.62B -3.86B -48.92B -3.68B -3.6B -154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
